Recurrent Adult Acute Myeloid Leukemia
Showing NaN - NaN of 15
Recurrent Adult Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Houston (drug, biological, other)
Completed
- Recurrent Adult Acute Myeloid Leukemia
- Refractory Acute Myeloid Leukemia
- Cytarabine
- +5 more
-
Houston, TexasM D Anderson Cancer Center
Jun 18, 2021
Acute Myeloid Leukemia, Adult Acute Monoblastic Leukemia, Adult Acute Monocytic Leukemia Trial in Canada, Puerto Rico, United
Completed
- Acute Myeloid Leukemia
- +27 more
- Caspofungin Acetate
- +2 more
-
Birmingham, Alabama
- +178 more
Mar 26, 2021
Recurrent Adult Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome Trial in Houston (BP1001, BP1001
Completed
- Recurrent Adult Acute Myeloid Leukemia
- +3 more
- BP1001
- BP1001 in combination with LDAC
-
Houston, TexasM. D. Anderson Cancer Center
May 26, 2020
Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22);
Completed
- Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
- +10 more
- Erlotinib Hydrochloride
- Laboratory Biomarker Analysis
-
Houston, TexasM D Anderson Cancer Center
Dec 18, 2019
Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic
Completed
- Adult Acute Megakaryoblastic Leukemia (M7)
- +14 more
- Akt inhibitor MK2206
- laboratory biomarker analysis
-
Houston, Texas
- +1 more
Jul 27, 2018
Adult Acute Monoblastic Leukemia (M5a), Adult Acute Monocytic Leukemia (M5b), Adult Acute Myeloblastic Leukemia With Maturation
Completed
- Adult Acute Monoblastic Leukemia (M5a)
- +21 more
- idarubicin
- +4 more
-
Birmingham, Alabama
- +81 more
May 21, 2018
Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Adult Acute Megakaryoblastic Leukemia, Adult Acute
Completed
- Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
- +16 more
- Clinical Observation
- Tipifarnib
-
Birmingham, Alabama
- +340 more
Mar 20, 2018
Recurrent Adult Acute Myeloid Leukemia, Untreated Adult Acute Myeloid Leukemia Trial in Chicago, Baltimore, Houston (Akt
Terminated
- Recurrent Adult Acute Myeloid Leukemia
- Untreated Adult Acute Myeloid Leukemia
- Akt Inhibitor GSK2141795
- +2 more
-
Chicago, Illinois
- +2 more
Apr 4, 2018
Previously Treated Myelodysplastic Syndrome, Recurrent Adult Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in
Completed
- Previously Treated Myelodysplastic Syndrome
- +5 more
- Cytarabine
- +4 more
-
Columbus, Ohio
- +1 more
Aug 1, 2017
Adult Acute Basophilic Leukemia, Adult Acute Eosinophilic Leukemia, Adult Acute Megakaryoblastic Leukemia Trial in Houston
Completed
- Adult Acute Basophilic Leukemia
- +23 more
- Sorafenib Tosylate
-
Houston, TexasM D Anderson Cancer Center
Apr 27, 2015
Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute
Terminated
- Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities
- +13 more
-
Houston, TexasM D Anderson Cancer Center
Sep 27, 2013
Adult Acute Promyelocytic Leukemia (M3), Blastic Phase Chronic Myelogenous Leukemia, Previously Treated MDS Trial in Houston
Completed
- Adult Acute Promyelocytic Leukemia (M3)
- +7 more
-
Houston, TexasM D Anderson Cancer Center
Jan 22, 2013
Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute
Completed
- Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities
- +15 more
- becatecarin
- laboratory biomarker analysis
-
Houston, TexasM D Anderson Cancer Center
Jan 22, 2013
Adult Acute Promyelocytic Leukemia (M3), Blastic Phase Chronic Myelogenous Leukemia, Childhood MDS Trial in Houston (BMS-214662,
Completed
- Adult Acute Promyelocytic Leukemia (M3)
- +10 more
- BMS-214662
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Jan 22, 2013
Chronic Myelomonocytic Leukemia, Previously Treated MDS, Recurrent Adult Acute Myeloid Leukemia Trial in Houston (liposomal
Completed
- Chronic Myelomonocytic Leukemia
- +4 more
- liposomal daunorubicin citrate
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Jan 22, 2013